Discount Agreements for Ustekinumab (Biologics) 2026-2027
The Techniker Krankenkasse is seeking partners for discount agreements for the active ingredient Ustekinumab. The contracts will run for a maximum of 12 months starting August 1, 2026.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
420 days remaining(LOT-0001)
Published